Choose the experimental features you want to try

This document is an excerpt from the EUR-Lex website

Document 52024XC05166

    Sažetak odluka Europske unije o odobrenjima za stavljanje u promet lijekova od 1. srpnja 2024. do 31. srpnja 2024.

    PUB/2024/799

    SL C, C/2024/5166, 30.8.2024, ELI: http://data.europa.eu/eli/C/2024/5166/oj (BG, ES, CS, DA, DE, ET, EL, EN, FR, GA, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)

    ELI: http://data.europa.eu/eli/C/2024/5166/oj

    European flag

    Službeni list
    Europske unije

    HR

    Serija C


    C/2024/5166

    30.8.2024

    Sažetak odluka Europske unije o odobrenjima za stavljanje u promet lijekova od 1. srpnja 2024. do 31. srpnja 2024.

    (Objavljeno u skladu s člankom 13. ili člankom 38. Uredbe (EZ) br. 726/2004 Europskog parlamenta i Vijeća  (1) ili Članak 5. Uredbe (EU) 2019/6 Europskog parlamenta i Vijeća  (2) )

    (C/2024/5166)

    Izdavanje odobrenja za stavljanje u promet (članak 13 Uredbe (EZ) br. 726/2004 Europskog parlamenta i Vijeća): Prihvaćeno

    Datum odluke

    Naziv lijeka

    INN (međunarodni nezaštićeni naziv lijeka)

    Nositelj odobrenja za stavljanje u promet

    Broj upisa u registar Zajednice

    Farmaceutski oblik

    Oznaka ATC (Anatomsko-terapijsko-kemijska klasifikacija lijekova)

    Datum obavijesti

    24.7.2024

    Apexelsin

    Paklitaksel

    WhiteOak Pharmaceutical B.V.

    Teleportboulevard 130, Amsterdam, 1043 EJ, Nederland

    EU/1/24/1835

    Prašak za disperziju za infuziju

    L01CD01

    26.7.2024

    24.7.2024

    Cejemly

    sugemalimab

    SFL Pharmaceuticals Deutschland GmbH

    Marie-Curie-Strasse 8, 79539 Loerrach, Deutschland

    EU/1/24/1833

    Koncentrat za otopinu za infuziju

    L01FF11

    25.7.2024

    24.7.2024

    DURVEQTIX

    fidanakogen elaparvovek

    Pfizer Europe MA EEIG

    Boulevard de la Plaine 17, 1050 Bruxelles, Belgique/ Pleinlaan 17, 1050 Brussel, België

    EU/1/24/1838

    Koncentrat za otopinu za infuziju

    Pending

    26.7.2024

    24.7.2024

    Kinpeygo

    budezonid

    STADA Arzneimittel AG

    Stadastraße 2-18, 61118 Bad Vilbel, Deutschland

    EU/1/22/1657

    Kapsula s prilagođenim oslobađanjem, tvrda

    A07EA06

    29.7.2024

    24.7.2024

    Pomalidomide Krka

    pomalidomid

    KRKA d d., Novo mesto

    Šmarješka cesta 6, 8501 Novo mesto, Slovenija

    EU/1/24/1832

    Kapsula, tvrda

    L04AX06

    25.7.2024

    24.7.2024

    Pomalidomide Zentiva

    Pomalidomid

    Zentiva, k.s.

    U Kabelovny 130, 102 37 Praha 10, Česká republika

    EU/1/24/1830

    Kapsula, tvrda

    L04AX06

    25.7.2024

    24.7.2024

    Zegalogue

    Dasiglukagona

    Zealand Pharma A/S

    Sydmarken 11, 2860 Soeborg, Danmark

    EU/1/24/1829

    Otopina za injekciju

    H04AA02

    25.7.2024

    26.7.2024

    Avzivi

    bevacizumab

    FGK Representative Service GmbH

    Heimeranstrasse 35, 80339 München, Deutschland

    EU/1/24/1834

    Koncentrat za otopinu za infuziju

    L01FG01

    30.7.2024

    26.7.2024

    Dasatinib Accord Healthcare

    dasatinib

    Accord Healthcare S.L.U.

    World Trade Center, Moll de Barcelona s/n, Edifici Est, 6a planta, 08039 Barcelona, España

    EU/1/24/1839

    Filmom obložena tableta

    L01EA02

    29.7.2024

    26.7.2024

    Pomalidomide Accord

    pomalidomid

    Accord Healthcare S.L.U.

    World Trade Center, Moll de Barcelona, s/n, Edifici Est 6a planta, 08039 Barcelona, España

    EU/1/24/1831

    Kapsula, tvrda

    L04AX06

    29.7.2024

    Izdavanje odobrenja za stavljanje u promet (članak 13 Uredbe (EZ) br. 726/2004 Europskog parlamenta i Vijeća): Odbijeno

    Datum odluke

    Naziv lijeka

    Nositelj odobrenja za stavljanje u promet

    Broj upisa u registar Zajednice

    Datum obavijesti

    22.7.2024

    Nezglyal

    Minoryx Therapeutics S.L.

    Calle Ernest Lluch 32 Tcm 3, 08302 Mataro, España

    -

    23.7.2024

    Izmjena odobrenja za stavljanje u promet (članak 13 Uredbe (EZ) br. 726/2004 Europskog parlamenta i Vijeća): Prihvaćeno

    Datum odluke

    Naziv lijeka

    Nositelj odobrenja za stavljanje u promet

    Broj upisa u registar Zajednice

    Datum obavijesti

    3.7.2024

    Comirnaty

    BioNTech Manufacturing GmbH

    An der Goldgrube 12, 55131 Mainz, Deutschland

    EU/1/20/1528

    4.7.2024

    5.7.2024

    Aldara

    Viatris Healthcare Limited

    Damastown Industrial Park, Mulhuddart, Dublin 15, Ireland

    EU/1/98/080

    8.7.2024

    5.7.2024

    Carbaglu

    Recordati Rare Diseases

    Immeuble Le Wilson, 70 avenue du Général de Gaulle, 92 800 Puteaux, France

    EU/1/02/246

    10.7.2024

    5.7.2024

    Cosentyx

    Novartis Europharm Limited

    Vista Building, Elm Park, Merrion Road, Dublin 4, Ireland

    EU/1/14/980

    8.7.2024

    5.7.2024

    Darunavir Viatris

    Viatris Limited

    Damastown Industrial Park, Mulhuddart, Dublin 15, DUBLIN, Ireland

    EU/1/16/1140

    8.7.2024

    5.7.2024

    Inrebic

    Bristol-Myers Squibb Pharma EEIG

    Plaza 254, Blanchardstown Corporate Park 2, D15 T867, Dublin 15, Ireland

    EU/1/20/1514

    8.7.2024

    5.7.2024

    Iressa

    AstraZeneca AB

    151 85 Södertälje, Sverige

    EU/1/09/526

    8.7.2024

    5.7.2024

    Jylamvo

    Oresund Pharma ApS

    Orient Plads 1, 2150 Nordhavn, Hovedstaden, Danmark

    EU/1/17/1172

    8.7.2024

    5.7.2024

    Lonquex

    Teva B.V.

    Swensweg 5, 2031 GA Haarlem, Nederland

    EU/1/13/856

    8.7.2024

    5.7.2024

    Neulasta

    Amgen Europe B.V.

    Minervum 7061, 4817 ZK Breda, Nederland

    EU/1/02/227

    8.7.2024

    5.7.2024

    NovoMix

    Novo Nordisk A/S

    Novo Allé, 2880 Bagsvaerd, Danmark

    EU/1/00/142

    8.7.2024

    5.7.2024

    Pergoveris

    Merck Europe B.V.

    Gustav Mahlerplein 102, 1082 MA Amsterdam, Nederland

    EU/1/07/396

    8.7.2024

    5.7.2024

    Ristaben

    Merck Sharp & Dohme B.V.

    Waarderweg 39, 2031 BN Haarlem, Nederland

    EU/1/10/621

    9.7.2024

    5.7.2024

    Ronapreve

    Roche Registration GmbH

    Emil-Barell-Strasse 1, 79639 Grenzach-Wyhlen, Deutschland

    EU/1/21/1601

    8.7.2024

    5.7.2024

    Saxenda

    Novo Nordisk A/S

    Novo Allé, 2880 Bagsvaerd, Danmark

    EU/1/15/992

    8.7.2024

    5.7.2024

    Sibnayal

    ADVICENNE

    262, rue du Faubourg Saint Honoré 75008 Paris, France

    EU/1/20/1517

    8.7.2024

    5.7.2024

    Temozolomide Accord

    Accord Healthcare S.L.U.

    World Trade Center, Moll de Barcelona, s/n, Edifici Est 6a planta, 08039 Barcelona, España

    EU/1/10/615

    8.7.2024

    5.7.2024

    Tigecycline Accord

    Accord Healthcare S.L.U.

    World Trade Center, Moll de Barcelona, s/n, Edifici Est 6a planta, 08039 Barcelona, España

    EU/1/19/1394

    8.7.2024

    5.7.2024

    TUKYSA

    Pfizer Europe MA EEIG

    Boulevard de la Plaine 17, 1050 Bruxelles, Belgique/ Pleinlaan 17, 1050 Brussel, België

    EU/1/20/1526

    11.7.2024

    5.7.2024

    ZTALMY

    Marinus Pharmaceuticals Emerald Limited

    10 Earlsfort Terrace, Dublin 2, D02 T380, Ireland

    EU/1/23/1743

    10.7.2024

    8.7.2024

    Sugammadex Amomed

    AOP Orphan Pharmaceuticals GmbH

    Leopold-Ungar-Platz 2, 1190 Wien, Österreich

    EU/1/22/1708

    11.7.2024

    8.7.2024

    Tevimbra

    BeiGene Ireland Limited

    10 Earlsfort Terrace, Dublin 2, D02 T380, Ireland

    EU/1/23/1758

    9.7.2024

    8.7.2024

    Victoza

    Novo Nordisk A/S

    Novo Allé, 2880 Bagsvaerd, Danmark

    EU/1/09/529

    9.7.2024

    12.7.2024

    Ocaliva

    ADVANZ PHARMA Limited

    Suite 17, Northwood House, Northwood Avenue, Santry, Dublin 9, Ireland

    EU/1/16/1139

    15.7.2024

    12.7.2024

    Ristfor

    Merck Sharp & Dohme B.V.

    Waarderweg 39, 2031 BN Haarlem, Nederland

    EU/1/10/620

    16.7.2024

    12.7.2024

    Soliris

    Alexion Europe SAS

    103-105 rue Anatole France, 92300 Levallois-Perret, France

    EU/1/07/393

    15.7.2024

    17.7.2024

    Accofil

    Accord Healthcare S.L.U.

    World Trade Center, Moll de Barcelona, s/n, Edifici Est 6a planta, 08039 Barcelona, España

    EU/1/14/946

    18.7.2024

    17.7.2024

    Fluenz

    AstraZeneca AB

    151 85 Södertälje, Sverige

    EU/1/24/1816

    18.7.2024

    17.7.2024

    Galvus

    Novartis Europharm Limited

    Vista Building, Elm Park, Merrion Road, Dublin 4, Ireland

    EU/1/07/414

    18.7.2024

    17.7.2024

    GAVRETO

    Blueprint Medicines (Netherlands) B.V.

    Gustav Mahlerplein 2, 1082 MA Amsterdam, Nederland

    EU/1/21/1555

    18.7.2024

    17.7.2024

    Minjuvi

    Incyte Biosciences Distribution B.V.

    Paasheuvelweg 25, 1105 BP Amsterdam, Nederland

    EU/1/21/1570

    18.7.2024

    17.7.2024

    Rekovelle

    Ferring Pharmaceuticals A/S

    Amager Strandvej 405, 2770 Kastrup, Danmark

    EU/1/16/1150

    23.7.2024

    17.7.2024

    Ritonavir Viatris

    Viatris Limited

    Damastown Industrial Park, Mulhuddart, Dublin 15, DUBLIN, Ireland

    EU/1/17/1242

    18.7.2024

    17.7.2024

    Tepkinly

    AbbVie Deutschland GmbH & Co. KG

    Knollstrasse, 67061 Ludwigshafen, Deutschland

    EU/1/23/1759

    18.7.2024

    18.7.2024

    Levetiracetam SUN

    Sun Pharmaceutical Industries Europe BV

    Polarisavenue 87, 2132 JH Hoofddorp, Nederland

    EU/1/11/741

    25.7.2024

    18.7.2024

    Retacrit

    Pfizer Europe MA EEIG

    Boulevard de la Plaine 17, 1050 Bruxelles, Belgique/ Pleinlaan 17, 1050 Brussel, België

    EU/1/07/431

    18.7.2024

    19.7.2024

    Hyrimoz

    Sandoz GmbH

    Biochemiestrasse 10, 6250 Kundl, Österreich

    EU/1/18/1286

    22.7.2024

    19.7.2024

    Piqray

    Novartis Europharm Limited

    Vista Building, Elm Park, Merrion Road, Dublin 4, Ireland

    EU/1/20/1455

    22.7.2024

    19.7.2024

    Pregabalin Viatris

    Viatris Limited

    Damastown Industrial Park, Mulhuddart, Dublin 15, DUBLIN, Ireland

    EU/1/15/997

    24.7.2024

    19.7.2024

    Scemblix

    Novartis Europharm Limited

    Vista Building, Elm Park, Merrion Road, Dublin 4, Ireland

    EU/1/22/1670

    22.7.2024

    19.7.2024

    Votrient

    Novartis Europharm Limited

    Vista Building, Elm Park, Merrion Road, Dublin 4, Ireland

    EU/1/10/628

    22.7.2024

    22.7.2024

    Avonex

    Biogen Netherlands B.V.

    Prins Mauritslaan 13, 1171 LP Badhoevedorp, Nederland

    EU/1/97/033

    23.7.2024

    22.7.2024

    Byfavo

    PAION Pharma GmbH

    Heussstraße 25, 52078 Aachen, Deutschland

    EU/1/20/1505

    25.7.2024

    22.7.2024

    Deferasirox Mylan

    Mylan Pharmaceuticals Limited

    Damastown Industrial Park, Mulhuddart, Dublin 15, DUBLIN, Ireland

    EU/1/19/1386

    23.7.2024

    22.7.2024

    Norvir

    AbbVie Deutschland GmbH & Co. KG

    Knollstrasse, 67061 Ludwigshafen, Deutschland

    EU/1/96/016

    23.7.2024

    22.7.2024

    Slenyto

    RAD Neurim Pharmaceuticals EEC SARL

    4 rue de Marivaux, 75002 Paris, France

    EU/1/18/1318

    25.7.2024

    22.7.2024

    Teriflunomide Mylan

    Mylan Pharmaceuticals Limited

    Damastown Industrial Park, Mulhuddart, Dublin 15, DUBLIN, Ireland

    EU/1/22/1698

    23.7.2024

    22.7.2024

    VITRAKVI

    Bayer AG

    D-51368 Leverkusen, Deutschland

    EU/1/19/1385

    23.7.2024

    23.7.2024

    Prometax

    Almirall, S.A.

    Ronda General Mitre, 151, 08022 Barcelona, España

    EU/1/98/092

    25.7.2024

    24.7.2024

    AUBAGIO

    Sanofi Winthrop Industrie

    82 avenue Raspail, 94250 Gentilly, France

    EU/1/13/838

    25.7.2024

    24.7.2024

    Buvidal

    Camurus AB

    Ideon Science Park, 223 70 Lund, Sverige

    EU/1/18/1336

    25.7.2024

    24.7.2024

    Bydureon

    AstraZeneca AB

    151 85 Södertälje, Sverige

    EU/1/11/696

    25.7.2024

    24.7.2024

    Bylvay

    Ipsen Pharma

    65 quai Georges Gorse, 92100 Boulogne-Billancourt, France

    EU/1/21/1566

    29.7.2024

    24.7.2024

    Caprelsa

    Sanofi B.V.

    Paasheuvelweg 25, 1105 BP Amsterdam, Nederland

    EU/1/11/749

    25.7.2024

    24.7.2024

    Fluad Tetra

    Seqirus Netherlands B.V.

    Paasheuvelweg 28, 1105 BJ Amsterdam, Nederland

    EU/1/20/1433

    25.7.2024

    24.7.2024

    Flucelvax Tetra

    Seqirus Netherlands B.V.

    Paasheuvelweg 28, 1105 BJ Amsterdam, Nederland

    EU/1/18/1326

    25.7.2024

    24.7.2024

    Idefirix

    Hansa Biopharma AB

    P.O. Box 785, 220 07 Lund, Sverige

    EU/1/20/1471

    25.7.2024

    24.7.2024

    Ilumetri

    Almirall, S.A.

    Ronda General Mitre, 151, 08022 Barcelona, España

    EU/1/18/1323

    29.7.2024

    24.7.2024

    JCOVDEN

    Janssen-Cilag International NV

    Turnhoutseweg 30, 2340 Beerse, België

    EU/1/20/1525

    25.7.2024

    24.7.2024

    Kaletra

    AbbVie Deutschland GmbH & Co. KG

    Knollstrasse, 67061 Ludwigshafen, Deutschland

    EU/1/01/172

    25.7.2024

    24.7.2024

    Leflunomide medac

    medac Gesellschaft für klinische Spezialpräparate mbH

    Theaterstraße 6, 22880 Wedel, Deutschland

    EU/1/10/637

    25.7.2024

    24.7.2024

    Leflunomide Zentiva

    Zentiva k.s.

    U kabelovny 130, 102 37 Praha 10, Česká republika

    EU/1/09/604

    29.7.2024

    24.7.2024

    Mvabea

    Janssen-Cilag International NV

    Turnhoutseweg 30, 2340 Beerse, België

    EU/1/20/1445

    25.7.2024

    24.7.2024

    Nexavar

    Bayer AG

    D-51368 Leverkusen, Deutschland

    EU/1/06/342

    25.7.2024

    24.7.2024

    Pregabalin Viatris

    Viatris Limited

    Damastown Industrial Park, Mulhuddart, Dublin 15, DUBLIN, Ireland

    EU/1/15/997

    25.7.2024

    24.7.2024

    Pyzchiva

    Samsung Bioepis NL B.V.

    Olof Palmestraat 10, 2616 LR Delft, Nederland

    EU/1/24/1801

    30.7.2024

    24.7.2024

    Skyrizi

    AbbVie Deutschland GmbH & Co. KG

    Knollstrasse, 67061 Ludwigshafen, Deutschland

    EU/1/19/1361

    25.7.2024

    24.7.2024

    Suboxone

    Indivior Europe Limited

    27 Windsor Place, Dublin 2, D02 DK44, Ireland

    EU/1/06/359

    25.7.2024

    24.7.2024

    TUKYSA

    Pfizer Europe MA EEIG

    Boulevard de la Plaine 17, 1050 Bruxelles, Belgique/ Pleinlaan 17, 1050 Brussel, België

    EU/1/20/1526

    30.7.2024

    26.7.2024

    Artesunate Amivas

    Amivas Ireland Ltd

    Suite 5, Second Floor, Station House, Railway Square, Waterford, Ireland

    EU/1/21/1582

    31.7.2024

    26.7.2024

    AYVAKYT

    Blueprint Medicines (Netherlands) B.V.

    Gustav Mahlerplein 2, 1082 MA Amsterdam, Nederland

    EU/1/20/1473

    29.7.2024

    26.7.2024

    Efficib

    Merck Sharp & Dohme B.V.

    Waarderweg 39, 2031 BN Haarlem, Nederland

    EU/1/08/457

    29.7.2024

    26.7.2024

    Eliquis

    Bristol-Myers Squibb/Pfizer EEIG

    Plaza 254, Blanchardstown Corporate Park 2, Dublin 15, D15 T867, Ireland

    EU/1/11/691

    29.7.2024

    26.7.2024

    Epidyolex

    Jazz Pharmaceuticals Ireland Ltd

    5th Floor, Waterloo Exchange, Waterloo Road, Dublin D04 E5W7, Ireland

    EU/1/19/1389

    30.7.2024

    26.7.2024

    Fareston

    Orion Corporation

    Orionintie 1, 02200 Espoo, Suomi

    EU/1/96/004

    29.7.2024

    26.7.2024

    Imcivree

    Rhythm Pharmaceuticals Netherlands B.V.

    Radarweg 29, 1043 NX Amsterdam, Nederland

    EU/1/21/1564

    29.7.2024

    26.7.2024

    Imfinzi

    AstraZeneca AB

    151 85 Södertälje, Sverige

    EU/1/18/1322

    29.7.2024

    26.7.2024

    Janumet

    Merck Sharp & Dohme B.V.

    Waarderweg 39, 2031 BN Haarlem, Nederland

    EU/1/08/455

    29.7.2024

    26.7.2024

    Orladeyo

    Biocryst Ireland Limited

    Block 4, Harcourt Centre, Harcourt Road, Dublin 2, D02 HW77, Ireland

    EU/1/21/1544

    29.7.2024

    26.7.2024

    Quinsair

    Chiesi Farmaceutici S.p.A.

    Via Palermo 26/A, 43122 Parma, Italia

    EU/1/14/973

    31.7.2024

    26.7.2024

    Teriflunomide Accord

    Accord Healthcare S.L.U.

    World Trade Center, Moll de Barcelona s/n, Edifici Est, 6a planta, 08039 Barcelona, España

    EU/1/22/1693

    29.7.2024

    26.7.2024

    Vabysmo

    Roche Registration GmbH

    Emil-Barell-Strasse 1, 79639 Grenzach-Wyhlen, Deutschland

    EU/1/22/1683

    29.7.2024

    26.7.2024

    Velmetia

    Merck Sharp & Dohme B.V.

    Waarderweg 39, 2031 BN Haarlem, Nederland

    EU/1/08/456

    29.7.2024

    26.7.2024

    Vumerity

    Biogen Netherlands B.V.

    Prins Mauritslaan 13, 1171 LP Badhoevedorp, Nederland

    EU/1/21/1585

    31.7.2024

    26.7.2024

    Zubsolv

    Accord Healthcare S.L.U.

    World Trade Center, Moll de Barcelona s/n, Edifici Est, 6a planta, 08039 Barcelona, España

    EU/1/17/1233

    29.7.2024

    29.7.2024

    Atazanavir Viatris

    Viatris Limited

    Damastown Industrial Park, Mulhuddart, Dublin 15, DUBLIN, Ireland

    EU/1/16/1091

    30.7.2024

    29.7.2024

    Jalra

    Novartis Europharm Limited

    Vista Building, Elm Park, Merrion Road, Dublin 4, Ireland

    EU/1/08/485

    1.8.2024

    29.7.2024

    Lopinavir/Ritonavir Viatris

    Viatris Limited

    Damastown Industrial Park, Mulhuddart, Dublin 15, DUBLIN, Ireland

    EU/1/15/1067

    30.7.2024

    29.7.2024

    Myalepta

    Chiesi Farmaceutici S.p.A.

    Via Palermo 26/A, 43122 Parma, Italia

    EU/1/18/1276

    30.7.2024

    29.7.2024

    Rasagiline Viatris

    Viatris Limited

    Damastown Industrial Park, Mulhuddart, Dublin 15, DUBLIN, Ireland

    EU/1/16/1090

    30.7.2024

    29.7.2024

    Xiliarx

    Novartis Europharm Limited

    Vista Building, Elm Park, Merrion Road, Dublin 4, Ireland

    EU/1/08/486

    1.8.2024

    Povlačenje odobrenja za stavljanje u promet (članak 13 Uredbe (EZ) br. 726/2004 Europskog parlamenta i Vijeća)

    Datum odluke

    Naziv lijeka

    Nositelj odobrenja za stavljanje u promet

    Broj upisa u registar Zajednice

    Datum obavijesti

    5.7.2024

    Evicel

    Omrix Biopharmaceuticals N.V.

    Leonardo Da Vincilaan 15, 1831 Diegem, België

    EU/1/08/473

    8.7.2024

    5.7.2024

    Tizveni

    BeiGene Ireland Limited

    10 Earlsfort Terrace, Dublin 2, D02 T380, Ireland

    EU/1/24/1797

    10.7.2024

    18.7.2024

    Esmya

    Gedeon Richter Plc.

    Gyömrői út 19-21, 1103 Budapest, Magyarország

    EU/1/12/750

    18.7.2024

    26.7.2024

    JCOVDEN

    Janssen-Cilag International NV

    Turnhoutseweg 30, 2340 Beerse, België

    EU/1/20/1525

    29.7.2024

    Izdavanje odobrenja za stavljanje u promet (članak 38 Uredbe (EZ) br. 726/2004 Europskog parlamenta i Vijeća; Članak 5. Uredbe (EU) 2019/6 Europskog parlamenta i Vijeća): Prihvaćeno

    Datum odluke

    Naziv lijeka

    INN (međunarodni nezaštićeni naziv lijeka)

    Nositelj odobrenja za stavljanje u promet

    Broj upisa u registar Zajednice

    Farmaceutski oblik

    Oznaka ATC (Anatomsko-terapijsko-kemijska klasifikacija lijekova)

    Datum obavijesti

    5.7.2024

    Nobilis Multriva RT+IBm+ND+Gm+REOm

    Ptičji metapneumovirus, virus ptičjeg zaraznog bronhitisa, virus Newcastleske bolesti, virus ptičje zarazne bolesti burze i cjepivo protiv ptičjeg reovirusa (inaktivirano)

    Intervet International B.V.

    Wim de Körverstraat 35, 5831 AN Boxmeer, Nederland

    EU/2/24/317

    Emulzija za injekciju

    QI01AA26

    8.7.2024

    17.7.2024

    Nobilis Multriva RT+IBm+ND+EDS

    Cjepivo protiv ptičjeg metapneumovirusa, virusa infektivnog bronhitisa, virusa Newcastleske bolesti i sindroma pada nesivosti, inaktivirano.

    Intervet International B.V.

    Wim de Körverstraat 35, 5831 AN Boxmeer, Nederland

    EU/2/24/316

    Emulzija za injekciju

    Pending

    18.7.2024

    Izmjena odobrenja za stavljanje u promet (članak 38 Uredbe (EZ) br. 726/2004 Europskog parlamenta i Vijeća; Članak 5. Uredbe (EU) 2019/6 Europskog parlamenta i Vijeća): Prihvaćeno

    Datum odluke

    Naziv lijeka

    Nositelj odobrenja za stavljanje u promet

    Broj upisa u registar Zajednice

    Datum obavijesti

    5.7.2024

    Felpreva

    Vetoquinol S.A.

    Magny-Vernois, 70200 Lure, France

    EU/2/21/277

    8.7.2024

    5.7.2024

    Forceris

    Ceva Santé Animale

    10 avenue de La Ballastière, 33500 Libourne, France

    EU/2/19/235

    8.7.2024

    5.7.2024

    Isemid

    Ceva Santé Animale

    10 avenue de La Ballastière, 33500 Libourne, France

    EU/2/18/232

    9.7.2024

    5.7.2024

    Nobivac LoVo L4

    Intervet International B.V.

    Wim de Körverstraat 35, 5831 AN Boxmeer, Nederland

    EU/2/23/304

    8.7.2024

    5.7.2024

    Vectra 3D

    Ceva Santé Animale

    10 avenue de La Ballastière, 33500 Libourne, France

    EU/2/13/156

    8.7.2024

    5.7.2024

    Vectra Felis

    Ceva Santé Animale

    10 avenue de La Ballastière, 33500 Libourne, France

    EU/2/14/165

    8.7.2024

    5.7.2024

    Virbagen Omega

    VIRBAC

    1ère Avenue - 2065m – L.I.D., 06516 CARROS, France

    EU/2/01/030

    8.7.2024

    8.7.2024

    Circovac

    CEVA-Phylaxia Co. Ltd

    Szállás u. 5, 1107 Budapest, Magyarország

    EU/2/07/075

    10.7.2024

    8.7.2024

    HorStem

    EquiCord S.L

    103-D Loeches, Polígono. Industrial Ventorro del Cano, Alcorcón, 28925 Madrid, España.

    EU/2/18/226

    11.7.2024

    11.7.2024

    BLUEVAC BTV

    CZ Vaccines S.A.U.

    A Relva s/n – Torneiros 36410 O Porriño Pontevedra, España

    EU/2/11/122

    12.7.2024

    11.7.2024

    Porcilis AR-T DF

    Intervet International B.V.

    Wim de Körverstraat 35, 5831 AN Boxmeer, Nederland

    EU/2/00/026

    12.7.2024

    Zainteresirane osobe koje žele na uvid dobiti javno izvješće o procjeni predmetnih lijekova i odluka koje se na njih odnose trebale bi se obratiti:

    European Medicines Agency

    Domenico Scarlattilaan 6

    1083 HS Amsterdam

    NETHERLANDS


    (1)   SL L 136, 30.4.2004, str. 1, ELI: https://data.europa.eu/eli/reg/2004/726/oj .

    (2)   SL L 4, 7.1.2019, str. 43, ELI: https://data.europa.eu/eli/reg/2019/6/oj .


    ELI: http://data.europa.eu/eli/C/2024/5166/oj

    ISSN 1977-1088 (electronic edition)


    Top